Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson(Lawrence Berkeley National Laboratory), Anguraj Sadanandam(École Polytechnique Fédérale de Lausanne), Peter Olson, William J. Gibb(Lawrence Berkeley National Laboratory), Morgan Truitt, Shenda Gu(Lawrence Berkeley National Laboratory), J. Cooc, Jennifer Weinkle(Lawrence Berkeley National Laboratory), Grace Kim(University of California, San Francisco), Lakshmi R. Jakkula(Lawrence Berkeley National Laboratory), Heidi S. Feiler(Lawrence Berkeley National Laboratory), Andrew H. Ko(University of California, San Francisco), Adam B. Olshen(UCSF Helen Diller Family Comprehensive Cancer Center), Kathleen L Danenberg, Margaret A. Tempero(University of California, San Francisco), Paul T. Spellman(Lawrence Berkeley National Laboratory), Douglas Hanahan(Swiss Cancer Center Léman), Joe W. Gray(Lawrence Berkeley National Laboratory)
Cited by 1,995Open Access
Abstract
Related Papers
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al.|New England Journal of Medicine|2004|11.5k